<div id="readability-page-1"><p>In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Pharvaris, with a price target of <span id="expert-recommendation-target">$60.00</span>.</p><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>Trucchio covers the Healthcare sector, focusing on stocks such as Atai Beckley N.V., Definium Therapeutics, and Alnylam Pharma. According to TipRanks, Trucchio has an average return of <span>27.8%</span> and a 52.26% success rate on recommended stocks. </p> <p>In addition to H.C. Wainwright, Pharvaris also received a Buy from Citizens JMP’s Jonathan Wolleben in a report issued yesterday. However, today, Bank of America Securities maintained a Hold rating on Pharvaris (NASDAQ: PHVS).</p></div>

PHVS

<p>H.C. Wainwright's Patrick Trucchio has reiterated a Buy rating on Pharvaris (PHVS) with a price target of $60.00. Trucchio, who covers the Healthcare sector, has an average return of 27.8% and a 52.26% success rate on his stock recommendations. Additionally, Jonathan Wolleben from Citizens JMP also issued a Buy rating for Pharvaris recently, while Bank of America Securities maintained a Hold rating on the stock.</p>

Tip Ranks

Pharvaris BV

iShares Biotechnology ETF

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

Ark Genomic Revolution ETF

VanEck Biotech ETF

VG Health

Invesco Biotechnology & Genome ETF

Direxion S&P Biotech Bull 3X

Health Care Select Sector SPDR

AtaiBeckley

Definium Therapeutics

Alnylam Pharma

Citizens Financial

Bank of America

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Pharvaris (PHVS) Receives a Buy from H.C. Wainwright